MedTrace Logo

In Vivo Evaluation of the Nipro Elisio™ Dialyzer

NCT01653808 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2012-09-14

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy and biocompatibility of the Nipro Elisio 210H dialyzer between two dialysis modalities, conventional hemodialysis and on line hemodiafiltration.

Conditions

Interventions

DEVICE

Elisio-210H

comparison of efficacy and biocompatibility of Elisio-210H dialyzer between conventional hemodialysis and on line hemodiafiltration

PROCEDURE

conventional hemodialysis

comparison of conventional hemodialysis with on line hemodiafiltration using Elisio-210H dialyzer

PROCEDURE

on line hemodiafiltration

comparison of on line hemodiafiltration with conventional hemodialysis using Elisio-210H dialyzer

Sponsors & Collaborators

  • Nipro Europe N.V.

    lead INDUSTRY

Principal Investigators

  • Bernard CANAUD, MD, Prof. · University Hospital Center of Montpellier, France

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01653808 on ClinicalTrials.gov